Spero.jpg
Spero Therapeutics Announces Proposed Rights Offering
January 30, 2020 08:00 ET | Spero Therapeutics, Inc.
CAMBRIDGE, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and...